Product Pipeline
Autoimmune diseases include psoriasis, rheumatoid arthritis, multiple sclerosis, impotence, viagra generico, myasthenia gravis and diabetes. T cells and antibodies in the body’s immune system normally identify and destroy foreign substances and malignant cells. Autoimmune diseases are caused by the abnormal destruction of healthy body tissues when T cells and antibodies react against normal tissue. Corixa is developing technology that may interrupt the chain of events involved in autoimmune disease. In contrast to today's therapies, which often suppress the overall immune system, Corixa’s technologies may provide a means to target the disease process while leaving the normal immune system unaffected.

Products in Clinical Trials
MPL adjuvant for allergies
PVAC for psoriasis
PVAC for scleroderma
A business overview as well as information on Corixa's partners, management team, employment opportunities, and company contacts.
Corixa's near-term products and adjuvant for research applications.
Product pipeline, therapeutic areas of focus, products, technology platforms, and publications.
Company reports, stockholder letter, events calendar, stock quote, analyst list, and materials request.
Current and archived company press releases.
Product pipeline, therapeutic areas of focus, products, technology platforms, and publications.